Albert R. Collinson, Ph.D. in

Albert R. Collinson, Ph.D.

Examiner · DISC type cs
Strategic Advisor at TIXiMED
📍 Marlborough, Massachusetts, United States

Albert Collinson is a seasoned biopharmaceutical executive with over 35 years of experience leading companies in the development and commercialization of novel therapeutics. He currently serves on the boards of Harbour BioMed and Privo Technologies. His peers recognize him as a charismatic leader, skilled scientist, and a great negotiator with a deep knowledge of the biopharma business.

He holds a Ph. D. in Biochemistry from Brandeis University and dual Bachelor of Science degrees from the University of Rhode Island and the University of Hawaii at Manoa. Based on his educational and professional history in Massachusetts and Rhode Island, he likely follows Boston-area sports.

Unique fact: He led TheracosBio from Phase 1 clinical studies to the successful FDA approval and commercial launch of Brenzavvy™ (bexagliflozin) for type 2 diabetes.

Read the full overview →
Current Role
Strategic Advisor
Location
Marlborough, Massachusetts, United States
Personality Overview

How Albert shows up

Overcautious
Tough To Convince
Process Oriented

The only way to convince them is by showing them examples and ample proof. They are quite aware of their needs and limitations, so they are unlikely to over-promise. Being observant comes to them naturally.

Priorities

Topics Albert cares about

Therapeutic Commercialization
His career focus is on successfully developing and commercializing novel therapeutics, taking drugs from clinical trials to market approval and launch.
Biotech Board Governance
Serves as a member of the board of directors for multiple global biopharmaceutical companies, including Harbour BioMed and Privo Technologies.
+5 more topics Login to view topics
Career

Work history

7-2025
Strategic Advisor
TIXiMED
9-2023
Member, Board of Directors
Privo Technologies Inc
7-2023
Member, Board of Directors, Harbour Biomed
HARBOUR BIOMED
7-2023
Advisor
TheracosBio
7-2009 - 7-2023
President and CEO
Theracos/TheracosBio
In the press

Media appearances

Harbour BioMed Appoints Dr. Albert R. Collinson as Independent Non‑Executive Director. Featured in PR Newswire
See now
Education
Ph.D.
Brandeis University
Bachelor of Science (BS)
University of Rhode Island
Social presence
in
Behavioral profile

DISC profile (public)

c

Calculativeness (C)

Calculativeness (C) reflects the degree to which a person is likely to be cautious, systematic and analytical. Those scoring high tend to emphasise quality and accuracy.

More profiles

Discover additional public profiles from our index.

Rafael de la Cruz Bravo
Rafael de la Cruz Bravo
Chief Executive Officer
Eight & Bob
 Gonzalo Fernandez-Nieto Cid
Gonzalo Fernandez-Nieto Cid
Partner and Chief Commercial Officer (CCO)
Eight & Bob
 Natan Milléo Giller
Natan Milléo Giller
Ecommerce & Digital Manager
Eight & Bob
CS
Carlota S.
AI Creative
Self-employed
Unlock the full playbookSee exactly how to sell to Albert. Free, 10 seconds.